Tonix Pharmaceuticals Holding Corp. - 10-Q Filing

Tonix Pharmaceuticals reports Q3 2026 financial results with segment performance across Tonmya, Zembrace Symtouch, and Tosymra.

3 articles from 1 source · updated

Coverage